Senticell® Secures Latest Funding Round

Senticell® secured an undisclosed amount in its latest Seed, adding another data point to the FinTech funding market.

Senticell® Raises an undisclosed amount in Funding

Senticell® secured an oversubscribed seed round to advance its RBC-based liquid biopsy platform, focusing on early disease detection and non-invasive diagnostics. Senticell® Closes Oversubscribed Seed Round to Advance RBC-Based Liquid Biopsy Platform.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Senticell® operates in FinTech. Senticell®'s financing adds to recent private-market activity.

Strategic Use of Funds

Advance RBC-Based Liquid Biopsy Platform.

Looking Ahead

Senticell® Closes Oversubscribed Seed Round to Advance RBC-Based Liquid Biopsy Platform

Source reference: original announcement/article.